Roadmap

Strategic Development Plan

Our high-level trajectory for building a next-generation, AI-powered genomic health platform.

Q1 2026
Technical Proof of Concept
Building our working prototype, integrating clinical-grade genomic databases with our proprietary analysis engine to establish the core technical foundation.
Q2 2026
Funding & Advisory Network
Pursuing early-stage funding and assembling a network of domain experts, clinical geneticists, and regulatory advisors to guide product development.
Q3 2026
Team & Production Build
Expanding the founding team across engineering and clinical roles, while transitioning from prototype to a production-grade, security-audited architecture.
Q4 2026
Validation & Early Access
Initiating structured validation with clinical partners, refining safety and accuracy benchmarks, and preparing for a compliant early-access programme.